Tokyo Tape
Sign in
← Taiyo Holdings

Quarterly report · Q2

4626.TEDINET S100S48Q
Period2023-04-01 → 2023-09-30
Filed2023-11-06
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥51.1bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥97.3bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥52.8bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥9.1bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥10.5bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥8.7bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥15.5bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥10.2bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥8.7bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥10.2bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥6.2bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥11.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥7.5bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥6.2bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥7.5bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥197.9bnat 2023-09-30Cons.Assets
Total assets¥187.3bnat 2023-03-31Cons.Assets
Total assets¥198.4bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥98.3bnat 2023-09-30Cons.Liabilities
Total liabilities¥94.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥99.6bnat 2023-09-30Cons.Net assets
Net assets / equity¥92.7bnat 2023-03-31Cons.Net assets
Net assets / equity¥93.4bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥45.4bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥47.1bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥45.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥47.1bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥57.2bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥51.2bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥11.0bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥22.7bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥12.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥12.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥13.2bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.0bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥13.9bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥2.9bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥111.642023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥65.72023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥203.712022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥133.322022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥68.862022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio50.3%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio49.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio47.1%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥1.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥1.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-09-30¥148m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30¥74m
jpcrp040300-q2r_E00913-000Electronics Materialsreportable segmentrevenue2023-04-01 → 2023-09-30¥34.7bn
jpcrp040300-q2r_E00913-000Electronics Materialsreportable segmentrevenue external2023-04-01 → 2023-09-30¥34.7bn
jpcrp040300-q2r_E00913-000Electronics Materialsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥0
jpcrp040300-q2r_E00913-000Electronics Materialsreportable segmentsegment profit2023-04-01 → 2023-09-30¥7.7bn
jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segmentrevenue2023-04-01 → 2023-09-30¥14.6bn
jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segmentrevenue external2023-04-01 → 2023-09-30¥14.6bn
jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segmentsegment profit2023-04-01 → 2023-09-30¥1.7bn
—segment totalrevenue2023-04-01 → 2023-09-30¥49.3bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥49.3bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥0
—segment totalsegment profit2023-04-01 → 2023-09-30¥9.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥51.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥51.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥148m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥9.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥1.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥1.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥142m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥30m
jpcrp040300-q2r_E00913-000Electronics Materialsreportable segmentrevenue2022-04-01 → 2022-09-30¥38.7bn
jpcrp040300-q2r_E00913-000Electronics Materialsreportable segmentrevenue external2022-04-01 → 2022-09-30¥38.7bn
jpcrp040300-q2r_E00913-000Electronics Materialsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥0
jpcrp040300-q2r_E00913-000Electronics Materialsreportable segmentsegment profit2022-04-01 → 2022-09-30¥10.4bn
jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segmentrevenue2022-04-01 → 2022-09-30¥12.4bn
jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segmentrevenue external2022-04-01 → 2022-09-30¥12.4bn
jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segmentsegment profit2022-04-01 → 2022-09-30¥1.0bn
—segment totalrevenue2022-04-01 → 2022-09-30¥51.1bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥51.1bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥0
—segment totalsegment profit2022-04-01 → 2022-09-30¥11.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥52.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥52.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥142m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥11.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 501
ItemContextValueUnit
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember52795000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E00913-000ElectronicsMaterialsReportableSegmentsMember0JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember0JPY
Transactions with other segmentsPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember142000000JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember142000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E00913-000ElectronicsMaterialsReportableSegmentsMember38684000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember12388000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember51073000000JPY
Net salesPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1864000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember52937000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E00913-000ElectronicsMaterialsReportableSegmentsMember10361000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember1023000000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember11385000000JPY
Operating incomePrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember30000000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember11415000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E00913-000ElectronicsMaterialsReportableSegmentsMember34729000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember14609000000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember49339000000JPY
Revenues from external customersCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1768000000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember51107000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E00913-000ElectronicsMaterialsReportableSegmentsMember0JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember0JPY
Transactions with other segmentsCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember148000000JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember148000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E00913-000ElectronicsMaterialsReportableSegmentsMember34729000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember14609000000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember49339000000JPY
Net salesCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1916000000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember51255000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E00913-000ElectronicsMaterialsReportableSegmentsMember7702000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember1701000000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember9403000000JPY
Operating incomeCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember74000000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember9478000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-11-06
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第78期（2024年3月期）第2四半期（自　2023年7月1日　至　2023年9月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)太陽ホールディングス株式会社
Company name in english cover pageFilingDateInstantTAIYO HOLDINGS CO., LTD.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　佐藤　英志
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)埼玉県比企郡嵐山町大字大蔵388番地
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)0493（62）7777（代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)執行役員経営企画室長　富岡　さやか
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都豊島区西池袋一丁目11番1号メトロポリタンプラザビル16階
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03（5953）5200（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)執行役員経営企画室長　富岡　さやか

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass